Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 3/20 | 0.44 |
| ▸ | RAB9A | P51151 | 3/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.44 |
| ▸ | HPGD | P15428 | 2/20 | 0.44 |
| ▸ | PARP1 | P09874 | 1/20 | 0.38 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.33 |
| ▸ | HSD17B3 | P37058 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.31 |
| ▸ | MET | P08581 | 1/20 | 0.31 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.31 |
| ▸ | MGLL | Q99685 | 1/20 | 0.30 |
| ▸ | CYP11B1 | P15538 | 1/20 | 0.30 |
| ▸ | CYP11B2 | P19099 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30284584 | 1.00 | NPC1 (0.44) | NPC1RAB9ASMN1; SMN2HPGDPARP1 | |
| SCHEMBL30633069 | 0.98 | NPC1 (0.43) | NPC1RAB9ASMN1; SMN2HPGDPARP1 | |
| SCHEMBL28153735 | 0.98 | NPC1 (0.43) | NPC1RAB9ASMN1; SMN2HPGDPARP1 | |
| SCHEMBL31612033 | 0.98 | NPC1 (0.43) | NPC1RAB9ASMN1; SMN2HPGDPARP1 | |
| SCHEMBL1356606 | 0.98 | NPC1 (0.43) | NPC1RAB9ASMN1; SMN2HPGDPARP1 | |
| SCHEMBL28893776 | 0.93 | NPC1 (0.40) | NPC1RAB9ASMN1; SMN2HPGDPARP1 | |
| SCHEMBL28981691 | 0.93 | NPC1 (0.40) | NPC1RAB9ASMN1; SMN2HPGDPARP1 | |
| SCHEMBL7901284 | 0.87 | RAB9A (0.42) | NPC1RAB9ASMN1; SMN2HPGDPARP1 | |
| SCHEMBL29809356 | 0.87 | RAB9A (0.42) | NPC1RAB9ASMN1; SMN2HPGDPARP1 | |
| SCHEMBL4206262 | 0.85 | KMT2A (0.50) | NPC1RAB9ASMN1; SMN2HPGDPARP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116284150-A | 2-hydroxy-1-naphthaldehyde thiosemicarbazone iridium (III) complex and preparation method and application thereof | 广西科技师范学院 | 2023-06-23 | — | — | CN | claimed |
| CN-101452999-B | A white light organic electroluminescent devices | UNIV TSINGHUA | 2012-01-04 | — | — | CN | claimed |
| CN-101452999-A | A white light organic electroluminescent devices | UNIV TSINGHUA (CN) | 2009-06-10 | — | — | CN | claimed |
| US-20080203360-A1 | Electroluminescent Materials Comprised with Mixture and Display Device Containing the Same | GRACEL DISPLAY INC. (KR) | 2008-08-28 | — | — | US | claimed |
| CN-101125913-A | 9,9-disubstitution-3,6-fluorenes polymer, preparing method and application thereof | UNIV SOUTH CHINA TECH (CN) | 2008-02-20 | — | — | CN | claimed |
| WO-2026101278-A1 | AUXILIARY ELECTRON TRANSPORT LAYER MATERIAL AND ORGANIC ELECTROLUMINESCENT ELEMENT COMPRISING SAME | 솔루스첨단소재 주식회사 | 2026-05-15 | — | — | WO | disclosed |
| US-20250380598-A1 | Organic Light-Emitting Display Device And Method For Manufacturing The Same | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-12-11 | — | — | US | disclosed |
| EP-4642197-A1 | ORGANIC ELECTROLUMINESCENT DEVICE | Solus Advanced Materials Co., Ltd. (KR) | 2025-10-29 | — | — | EP | disclosed |
| EP-4642198-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | Solus Advanced Materials Co., Ltd. (KR) | 2025-10-29 | — | — | EP | disclosed |
| US-12433138-B2 | Organic light-emitting display device and method for manufacturing the same | SAMSUNG DISPLAY CO., LTD. (KR) | 2025-09-30 | — | — | US | disclosed |
| US-20250295032-A1 | COMPOSITION FOR ORGANIC ELECTROLUMINESCENT DEVICE AND ORGANIC ELECTROLUMINESCENT DEVICE COMPRISING SAME | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2025-09-18 | — | — | US | disclosed |
| US-20250287837-A1 | ORGANIC ELECTROLUMINESCENT ELEMENT | SOLUS ADVANCED MATERIALS CO., LTD. (KR) | 2025-09-11 | — | — | US | disclosed |
| US-20060199943-A1 | White-emitting copolymers, representation and use thereof | OVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2006-09-07 | — | — | US | disclosed |
| EP-1670844-A1 | WHITE-EMITTING COPOLYMERS, REPRESENTATION AND USE THEREOF | MERCK PATENT GmbH (DE) | 2006-06-21 | — | — | EP | disclosed |
| US-7026478-B2 | Iron catalyzed cross coupling reactions of aromatic compounds | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2006-04-11 | — | — | US | disclosed |
| WO-2005030827-A1 | WHITE-EMITTING COPOLYMERS, REPRESENTATION AND USE THEREOF | COVION ORGANIC SEMICONDUCTORS GMBH (DE) | 2005-04-07 | — | — | WO | disclosed |
| US-20030220498-A1 | Iron catalyzed cross coupling reactions of aromatic compounds | STUDIENGESELLSCHAFT KOHLE MBH (DE) | 2003-11-27 | — | — | US | disclosed |
| US-4801593-A | VIRICIDE FOR RHINITIS VIRUS CONTAINING 2-PHENYLTETRALIN DERIVATIVE | BURROUGHS WELLCOME CO. (US) | 1989-01-31 | — | — | US | disclosed |
| EP-0025598-B1 | THE USE OF 2-PHENYLTETRALIN DERIVATIVES, OR HETEROCYCLIC ANALOGUES, IN MEDICINE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | THE WELLCOME FOUNDATION LIMITED (GB) | 1984-08-01 | — | — | EP | disclosed |
| EP-0025598-A1 | The use of 2-phenyltetralin derivatives, or heterocyclic analogues, in medicine and pharmaceutical compositions containing them | THE WELLCOME FOUNDATION LIMITED (GB) | 1981-03-25 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030220498-A1 | Iron catalyzed cross coupling reactions of aromatic compounds | ARRB1, RBX1, CYP4X1 | NPC1 849/4885RAB9A 1526/4885SMN1; SMN2 2701/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.